Theravance Biopharma, Inc.
US ˙ NasdaqGM ˙ KYG8807B1068

Introduction

This page provides a comprehensive analysis of the known insider trading history of Donal O'Connor. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Donal O'Connor has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:TBPH / Theravance Biopharma, Inc. Director 74,204
US:PRGO / Perrigo Company plc Director 30,637
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Donal O'Connor. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases TBPH / Theravance Biopharma, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in TBPH / Theravance Biopharma, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TBPH / Theravance Biopharma, Inc. Insider Trades
Insider Sales TBPH / Theravance Biopharma, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in TBPH / Theravance Biopharma, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2019-05-17 TBPH O'Connor Donal 2,673 20.1899 2,673 20.1899 53,968 20 15.6 -12,268 -22.73
2019-05-16 TBPH O'Connor Donal 1,327 21.0000 1,327 21.0000 27,867

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TBPH / Theravance Biopharma, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Donal O'Connor as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-21 2025-05-19 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 10,649 74,204 16.76
2025-05-16 2025-05-14 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -4,754 30,637 -13.43 26.01 -123,652 796,868
2025-05-16 2025-05-14 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 9,904 35,391 38.86 26.01 257,603 920,520
2024-05-16 2024-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -4,207 25,487 -14.17 30.22 -127,136 770,217
2024-05-16 2024-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 8,764 29,694 41.87 30.22 264,848 897,353
2024-05-10 2024-05-08 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 10,537 63,555 19.87
2023-05-19 2023-05-17 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -3,734 20,930 -15.14 32.86 -122,699 687,760
2023-05-19 2023-05-17 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 7,778 24,664 46.06 32.86 255,585 810,459
2023-05-04 2023-05-02 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 9,132 53,018 20.81
2022-11-23 2022-11-22 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
D - Sale to Issuer -10,000 43,886 -18.56 10.50 -105,000 460,803
2022-05-19 2022-05-17 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -6,599 0 -100.00
2022-05-19 2022-05-17 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 7,778 7,778
2022-05-19 2022-05-17 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -3,168 16,886 -15.80 38.57 -122,190 651,293
2022-05-19 2022-05-17 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 6,599 20,054 49.04 38.57 254,523 773,483
2022-04-28 2022-04-26 4 TBPH Theravance Biopharma, Inc.
Share Option (Right to Buy)
A - Award 28,000 28,000
2022-04-28 2022-04-26 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 9,852 53,886 22.37
2021-05-19 2021-05-17 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 6,599 6,599
2021-05-11 2021-05-07 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -5,804 0 -100.00
2021-05-11 2021-05-07 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -2,786 13,455 -17.15 42.96 -119,687 578,027
2021-05-11 2021-05-07 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 5,804 16,241 55.61 42.96 249,340 697,713
2021-04-29 2021-04-27 4 TBPH Theravance Biopharma, Inc.
Share Option (Right to Buy)
A - Award 6,000 6,000
2021-04-29 2021-04-27 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 9,828 44,034 28.73
2020-05-19 2020-05-15 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -6,054 0 -100.00
2020-05-19 2020-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -2,906 10,437 -21.78 52.76 -153,321 550,656
2020-05-19 2020-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 6,054 13,343 83.06 52.76 319,409 703,977
2020-05-11 2020-05-07 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 5,804 5,804
2020-04-30 2020-04-28 4 TBPH Theravance Biopharma, Inc.
Share Option (Right to Buy)
A - Award 6,000 6,000
2020-04-30 2020-04-28 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 6,635 34,206 24.07
2019-05-20 2019-05-17 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
S - Sale -2,673 27,571 -8.84 20.19 -53,968 556,656
2019-05-20 2019-05-16 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
S - Sale -1,327 30,244 -4.20 21.00 -27,867 635,124
2019-05-17 2019-05-15 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -3,971 0 -100.00
2019-05-17 2019-05-15 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 6,054 6,054
2019-05-17 2019-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -1,907 7,289 -20.74 49.55 -94,492 361,170
2019-05-17 2019-05-15 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 3,971 9,196 76.00 49.55 196,763 455,662
2019-05-02 2019-04-30 4 TBPH Theravance Biopharma, Inc.
Share Option (Right to Buy)
A - Award 6,000 6,000
2019-05-02 2019-04-30 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 8,385 31,571 36.16
2018-06-08 2018-06-06 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise 4,265 0 -100.00
2018-06-08 2018-06-06 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -2,218 5,225 -29.80 73.22 -162,402 382,574
2018-06-08 2018-06-06 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 4,265 7,443 134.20 73.22 312,283 544,976
2018-05-17 2018-05-15 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 3,971 3,971
2018-05-03 2018-05-01 4 TBPH Theravance Biopharma, Inc.
Share Option (Right to Buy)
A - Award 6,000 6,000
2018-05-03 2018-05-01 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 8,186 23,186 54.57
2017-06-08 2017-06-06 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 4,265 4,265
2017-06-02 2017-05-31 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -3,263 0 -100.00
2017-06-02 2017-05-31 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -1,697 3,178 -34.81 72.85 -123,626 231,517
2017-06-02 2017-05-31 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 3,263 4,875 202.42 72.85 237,710 355,144
2017-05-19 2016-05-19 4/A PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 3,263 3,263
2017-05-18 2017-05-17 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 6,000 15,000 66.67
2016-05-23 2016-05-19 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 3,263 3,263
2016-05-06 2016-05-04 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -924 0 -100.00
2016-05-06 2016-05-04 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -481 1,612 -22.98 95.70 -46,032 154,268
2016-05-06 2016-05-04 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 924 2,093 79.04 95.70 88,427 200,300
2016-05-05 2016-05-03 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 6,000 9,000 200.00
2015-11-17 2015-11-13 4 PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -1,929 0 -100.00
2015-11-17 2015-11-13 4 PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -926 1,247 -42.61 146.90 -136,029 183,184
2015-11-17 2015-11-13 4 PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 1,929 2,173 790.57 146.90 283,370 319,214
2015-11-17 2015-11-13 4/A PRGO PERRIGO Co plc
Restricted Stock Units
M - Exercise -1,929 0 -100.00
2015-11-17 2015-11-13 4/A PRGO PERRIGO Co plc
Ordinary Shares
F - Taxes -1,004 1,169 -46.20 146.90 -147,488 171,726
2015-11-17 2015-11-13 4/A PRGO PERRIGO Co plc
Ordinary Shares
M - Exercise 1,929 2,173 790.57 146.90 283,370 319,214
2015-11-06 2015-11-04 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 924 924 162.29 149,956 149,956
2015-10-23 2015-10-21 4 TBPH Theravance Biopharma, Inc.
Share Option (Right to Buy)
A - Award 12,000 12,000
2015-10-23 2015-10-21 4 TBPH Theravance Biopharma, Inc.
Ordinary Shares
A - Award 3,000 3,000
2014-11-17 2014-11-13 4 PRGO PERRIGO Co plc
Restricted Stock Units
A - Award 1,929 1,929
2014-11-14 3 PRGO PERRIGO Co plc
Ordinary Shares
1,686
2014-11-14 3 PRGO PERRIGO Co plc
Ordinary Shares
2,640
2014-11-14 3 PRGO PERRIGO Co plc
Ordinary Shares
1,686
2014-11-14 3 PRGO PERRIGO Co plc
Ordinary Shares
2,640
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)